Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. (Q48355461)

10 February 2018

review article

1 reference

title

Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. (English)

1 reference

10 February 2018

0 references

Kent JM

1

1 reference

10 February 2018

Coplan JD

series ordinal

2

1 reference

10 February 2018

Gorman JM

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

published in

Biological Psychiatry

1 reference

10 February 2018

volume

44

1 reference

10 February 2018

issue

9

1 reference

10 February 2018

page(s)

812-824

1 reference

10 February 2018

New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Prolactin response to dl-fenfluramine in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Fluoxetine: a review of receptor and functional effects and their clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Relays from the spinal cord and solitary nucleus through the parabrachial nucleus to the forebrain in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Neurotransmitters in the CNS control of breathing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Double-blind pilot trial of desipramine versus fluoxetine in panic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Physiological evidence concerning importance of the amygdaloid nuclear region in the integration of circulatory function and emotion in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Serotonin function in anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sertraline in social phobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Fluvoxamine in civilians with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

The role of the amygdala in fear and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

5-HT and mechanisms of defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Stimulation of the amygdala by glutamate facilitates corticotropin-releasing factor release from the median eminence and activation of the hypothalamic-pituitary-adrenal axis in stressed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Treatment of spontaneous panic attacks with chlomipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Ventilatory physiology of patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

5-Hydroxytryptamine pathways in anxiety and its treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Origin of serotonin-containing projections to the ventral respiratory group in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

5-Hydroxytryptamine stimulates corticosteroid-sensitive CRF release from cultured foetal hypothalamic cells. Role of protein kinases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

An indirect projection from the nucleus of the solitary tract to the central nucleus of the amygdala via the parabrachial nucleus in the rat: a light and electron microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Influence of the dorsal and median raphe nuclei on neurons in the periaqueductal gray matter: role of 5-hydroxytryptamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Paroxetine in social phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sertraline in the treatment of patients with social phobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Serotonin in Panic Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sertraline in social phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sensations Evoked by Stimulation in the Midbrain of Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

High-affinity platelet [3H]LSD binding is decreased in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Serotonin and the control of ventilation in awake rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Treatment of social phobia with fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Paroxetine efficacy in the treatment of generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sertraline in the treatment of rape victims with posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Amygdaloid and basal forebrain direct connections with the nucleus of the solitary tract and the dorsal motor nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Fluoxetine reduces explosiveness and elevates mood of vietnam combat vets with PTSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Fluoxetine in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Fenfluramine provocation of anxiety in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Sertraline in social phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

7 January 2021

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

7 January 2021

The treatment of phobic anxiety by zimelidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900210-8

7 January 2021

10.1016/S0006-3223(98)00210-8

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9807637

1 reference

10 February 2018